Methylation status of the reelin promoter region in the brain of schizophrenic patients
被引:107
作者:
Tochigi, Mamoru
论文数: 0引用数: 0
h-index: 0
机构:
RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, Japan
Grad Sch Med, Dept Neuropsychiat, Tokyo, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Tochigi, Mamoru
[2
,3
]
Iwamoto, Kazuya
论文数: 0引用数: 0
h-index: 0
机构:
RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Iwamoto, Kazuya
[2
]
Bundo, Miki
论文数: 0引用数: 0
h-index: 0
机构:
RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Bundo, Miki
[2
]
Komori, Atsuko
论文数: 0引用数: 0
h-index: 0
机构:
RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Komori, Atsuko
[2
]
Sasaki, Tsukasa
论文数: 0引用数: 0
h-index: 0
机构:
Univ Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Grad Sch Med, Dept Neuropsychiat, Tokyo, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Sasaki, Tsukasa
[1
,3
]
Kato, Nobumasa
论文数: 0引用数: 0
h-index: 0
机构:
Grad Sch Med, Dept Neuropsychiat, Tokyo, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Kato, Nobumasa
[3
]
Kato, Tadafumi
论文数: 0引用数: 0
h-index: 0
机构:
RIKEN, Brain Sci Inst, Lab Mol Dynam Mental Disorders, Wako, Saitama, JapanUniv Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
Kato, Tadafumi
[2
]
机构:
[1] Univ Tokyo, Grad Sch Med, Hlth Serv Ctr, Tokyo, Japan
DNA methylation;
epigenetics;
postmortem brain;
pyrosequencing;
reelin;
schizophrenia;
D O I:
10.1016/j.biopsych.2007.07.003
中图分类号:
Q189 [神经科学];
学科分类号:
071006 ;
摘要:
Background: Hypermethylation of the reelin (RELN) promoter region and the reduced levels of its messenger RNA and protein have been implicated in the pathophysiology of schizophrenia. We intended a technical replication of recent studies that observed hypermethylation of CpG or CpNpG sites in the RELN promoter region in the brain of schizophrenic patients. Methods: The DNA methylation status of the promoter region of RELN was examined by using the pyrosequencing method in the prefrontal cortices of 14 patients with schizophrenia and 13 control subjects. Results: All of the CpG and two proposed CpNpG sites analyzed showed no detectable DNA methylation (< 5%) in both control subjects and patients with schizophrenia. No detectable DNA methylation was observed in both gray and white matter, excluding the possibility of cellular heterogeneity of start materials. Conclusions: We did not confirm the hypermethylation of the RELN promoter region in the brains of schizophrenic patients, suggested in the previous studies.